您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

戴維震醫師

一般消化系統疾病診治、消化性潰瘍疾病、胃腸蠕動疾病(胃食道逆流疾病,食道弛緩不能症)、胃幽門螺旋桿菌診治、內視鏡診治、內視鏡黏膜下層剝離術、發炎性腸道疾病診治、膠囊內視鏡、減重縮胃內視鏡、經口內視鏡食道括約肌切開術、巴瑞特氏食道黏膜燒灼術、內視鏡抗逆流手術、高解析度食道壓力檢測、食道酸鹼值檢測
  • 國語,英語,閩南語
  • 副教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 長庚大學 兼任副教授(2020.08)
    • 高雄長庚紀念醫院 胃腸肝膽科系副系主任(2020.07)
    • 高雄長庚紀念醫院 胃腸肝膽科系副教授級主治醫師
    • 台灣小腸醫學會 第四屆理事 (2022.04)
    • 台灣胃腸神經與蠕動學會 第三屆監事
    • 台灣消化系內視鏡醫學會 第十一屆理事
  • 學歷
    • 高雄醫學大學醫學系畢
    • 日本東京國立癌病中心中央病院短期進修---消化道早期癌症內視鏡切除術 (2010年6月及2012年7月)
  • 經歷
    • 高雄長庚醫院內科部住院醫師
    • 高雄長庚醫院胃腸肝膽科系研究員
    • 高雄長庚紀念醫院 胃腸肝膽科系助理教授級主治醫師
    • 高雄市立鳳山醫院委託高雄長庚醫院經營 胃腸肝膽科主治醫師
    • 台灣小腸醫學會 第1.2.3屆監事
    • 正修科技大學 兼任助理教授
    • 長庚大學 兼任助理教授
    • 台灣消化系內視鏡醫學會 第九屆副秘書長
  • 學會與認證
    • 台灣內科醫學會專科醫師及指導醫師
    • 台灣消化系醫學會消化內科專科醫師及指導醫師
    • 台灣消化系內視鏡醫學會消化系內視鏡專科醫師
    • 中華民國醫用超音波學會超音波專業醫師
    • 台灣肝癌醫學會專科醫師
    • 台灣醫學教育學會一般醫學師資
  • 論文及期刊發表
    • Tsai YC, Tai WC*, Liang CM, Wu CK, Tsai MC, Hu WH, Huang PY, Chen CH, Kuo YH, Yao CC*, Chuah SK.. Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease. J Microbiol Immunol Infect. 2024 Oct 1:S1684-1182(24)00184-1. doi: 10.1016/j.jmii.2024.09.006. (SCI)
      生物製劑治療後腸道微生物群及厚壁菌門/擬桿菌門比例的變化在發炎症性腸病中的研究
    • Tai WC, Wu IT, Wang HM, Huang PY, Yao CC, Wu CK, Yang SC, Liang CM*, Hsu PI, Chuah SK. The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan. J Microbiol Immunol Infect. 2024 Aug;57(4):601-608. (SCI)
      比較埃索美拉唑基礎和拉百樂唑基礎高劑量雙重療法在首線幽門螺旋桿菌的根除治療效果- 台灣多中心實際研究報告
    • Lin WC, Tai WC(Co-first), Chang CH, Tu CH, Feng IC, Shieh MJ, Chung CS, Yen HH, Chou JW, Wong JM, Liu YH, Huang TY, Chuang CH, Tsai TJ, Chiang FF, Lu CY, Hsu WH, Yu FJ, Chao TH, Wu DC, Ho AS, Lin HH, CFeng CL, Wu KL, Wong MW, Tung CC, Lin CC, Chen CC, Hu HM, Lu LS, Wei SC*. Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study. Inflamm Bowel Dis. 2023 Nov 2;29(11):1730-1740. (SCI)
      生物製劑治療發炎性腸道疾病的效用與安全性：台灣多中心前瞻性研究
    • Tai WC, Yang SC, Yao CC, Wu CK , Liu AC, Lee CH, Kuo YH, Chuah SK*, Liang CM*. The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naive Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial. Infect Dis Ther. 2023 May;12(5):1415-1427. (SCI)
      比較新的第一線幽門螺旋桿菌除菌治療效果—隨機試驗之台灣報告
    • Lee YC, Tai WC*, Wu KL, Yao CC, Chuah SK. Per oral endoscopic myotomy for achalasia: A Taiwanese single-center experience. Adv Dig Med. 2022 Dec;9:241–246.
      經口內視鏡食道括約肌切開術治療食道弛緩不能：一個高雄醫學中心的經驗
    • Ko CY, Yao CC, Li YC, Lu LS, Chou YP, Hu ML, Chiu YC, Chuah SK, Tai WC*. Clinical outcomes of endoscopic submucosal dissection for colorectal neoplasms: A single-center experience in Southern Taiwan.PLoS One. 2022 Oct 7;17(10):e0275723. (SCI)
      針對大腸腫瘤執行內視鏡下黏膜剝離術之回溯性分析：南台灣單一醫學中心經驗分享
    • Huang TH, Yang SC*, Tai WC*, Liang CM, Kuo CM, Yao CC, Wu CK, Kuo YH, Chou YP, Lee CH, Wu KL, Chuah SK. The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance. Biomed J. 2021 Dec;44(6S2):S275-S281. (SCI)
      第一線胃幽門螺旋桿菌使用不含鉍的四合一治療法隨時間及抗藥性演變之根除成功率評估
    • Tai WC, Wu KL*, Chuah SK*. An update on endoscopic treatment for achalasia: From peroral endoscopic myotomy to endolumenal functional lumen imaging probe. Adv Dig Med. 2021 Mar;8:8–9.(台灣消化醫學雜誌)
      結合下食道弛緩不能症舊的診斷和治療的及新進展-綜論
    • Tai WC, Liang CM, Bi KW, Kuo CM*, Lu LS, Wu CK, Yang SC, Kuo YH, Lee CH, Huang CF, Hsu CN, Hsu PI, Wu DC, Hu TH, Wu KL, Chuah SK*. A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial. Infect Drug Resist. 2019 Sep 16;12:2923-2931. (SCI)
      比較以DEXLANSOPRAZOLE MR和以LANSOPRAZOLE為基礎不含鉍劑四合一幽門螺旋桿菌第一線治療之效益:一前瞻性研究比較
    • Tai WC, Liang CM, Kuo CM, Huang PY, Wu CK, Yang SC, Kuo YH, Lin MT, Lee CH, Hsu CN, Wu KL, Hu TH, Chuah SK*. A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial. J Antimicrob Chemother. 2019 Jun 1;74(6):1718-1724. (SCI)
      十四天含 esomeprazole及 amoxicillin「高劑量二合療法」在第一線幽門螺旋桿菌除菌治療可以達到高療效: 隨機試驗報告
    • Chuah SK, Lim CS, Liang CM, Lu HI,Wu KL,Changchien CS, Tai WC*. Bridging the Gap between Advancements in the Evolution of Diagnosis and Treatment towards Better Outcomes in Achalasia. BioMed Research International. 2019 Feb 6; 2019: 8549187. (SCI) Review
      下食道弛緩不能症之診斷與治療新進展：邁向最佳化療效的橋樑
    • Wang HM, Liang CM, Wu CK, Chiu YC, Chou YP, Wu KL, Huang CC, Chuah SK, Tai WC*, Lu LS. Metachronous duodenal neuroendocrine tumors treated by endoscopic submucosal dissection. Advances in Digestive Medicine. 2017 June 2; 4(2):71-75. 台灣消化醫學雜誌

    • Wu CK, Liang CM, Hsu CN, Hung TH, Yuan LT, Nguang SH, Wang JW, Tseng KL, Ku MK8, Yang SC, Tai WC*, Shih CW, Hsu PI, Wu DC, Chuah SK. The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation. PLoS One. 2017 Jan 24;12(1):e0169884. (SCI)

    • Tsai CE, Liang CM, Lee CH, Kuo YH, Wu KL, Chiu YC, Tai WC*, Chuah SK. First-line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan. Kaohsiung J Med Sci. 2016 Aug;32(8):397-402. (SCI)

    • Chuah SK(co-first), Liang CM(co-first), Lee CH, Chiou SS, Chiu YC, Hu ML, Wu KL, Lu LS, Chou YP, Chang KC, Kuo CH, Kuo CM, Hu TH, Tai WC*. A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication. Medicine (Baltimore). 2016 May;95(19):e3586. (SCI)

    • Wu IT, Chuah SK, Lee CH, Liang CM, Lu LS, Kuo YH, Yen YH, Hu ML, Chou YP, Yang SC, Kuo CM, Kuo CH, Chiou SS, Chien CC, Chiang YS, Chiou SS, Hu TH, Tai WC*. Five-year sequential changes in secondary antibiotic resistances of Helicobacter pylori in Taiwan. World J Gastroenterol. 2015 Oct 7; 21(37): 10669-10674. (SCI)

    • Kuo MT, Yang SC(co-first), Lu LS(co-first), Hsu CN, Kuo YH, Kuo CH, Liang CM, Kuo CM, Wu CK, Tai WC*, Chuah SK. Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease. BMC Gastroenterol. 2015 May 20;15:61. (SCI)

    • Yao CC, Wu IT (co-first), Lu LS, Lin SC, Liang CM, Kuo YH, Yang SC, Wu CK, Wang HM, Kuo CH, Chiou SS, Wu KL, Chiu YC, Chuah SK, Tai WC*. Endoscopic Management of Foreign Bodies in the Upper Gastrointestinal Tract of Adults. Biomed Res Int. 2015 July; 2015:658602. (SCI)
      成人上消化道異物的內視鏡治療
    • Tai WC, Liang CM(co-first), Lee CH, Chiu CH, Hu ML, Lu LS, Kuo YH, Kuo CM, Yen YH, Kuo CH, Chiou SS, Wu KL, Chiu YC, Hu TH, Chuah SK*. Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A” Success Rate for First-Line Helicobacter pylori Eradication. Biomed Res Int. 2015 Jan;2015:623732. (SCI)

    • Liang CM, Cheng JW(co-first), Kuo CM, Chang KC, Wu KL, Tai WC*, Chiu KW, Chiou SS, Lin MT, Hu TH, Chuah SK. Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice. Biomed J. 2014 Sep-Oct.37(5):326-330. 長庚醫誌

    • Chuah SK, Tai WC(co-first), Lee CH*, Liang CM, Hu TH. Quinolone-Containing Therapies in the Eradication of Helicobacter pylori. BioMed Research International. 2014 Aug.; 2014 (2014): 151543. Review (SCI)

    • Tai WC, Lee CH, Chiou SS, Kuo CM, Kuo CH, Liang CM, Lu LS, Chiu CH, Wu KL, Chiu YC, Hu TH, Chuah SK*. The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication. PLoS One. 2014 Aug 20;9(8):e105822. (SCI)

    • Wu TC, Chuah SK, Chang KC, Wu CK, Kuo CH, Wu KL, Chiu YC, Hu TH, Tai WC*. Outcome of holiday and nonholiday admission patients with acute peptic ulcer bleeding: a real-world report from southern taiwan. Biomed Res Int. 2014 July;2014:906531. (SCI)

    • Tai WC, Chiu CH(co-first), Liang CM, Chang KC, Kuo CM, Chiu YC, Wu KL, Hu ML, Chou YP, Chiou SS, Chiu KW, Kuo CH, Hu TH, Lin MT, Chuah SK*. Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan. Gastroenterol Res Pract. 2013 Oct.; 2013:932478. (SCI)

    • Kao SS, Chen WC, Hsu PI, Chuah SK, Lu CL, Lai KH, Tsai FW, Chang CC, Tai WC*. The Frequencies of Gastroesophageal and Extragastroesophageal Symptoms in Patients with Mild Erosive Esophagitis, Severe Erosive Esophagitis, and Barrett's Esophagus in Taiwan. Gastroenterol Res Pract. 2013;2013:480325. (SCI)

    • Lu LS, Lin SC, Kuo CM, Tai WC*, Tseng PL, Chang KC, Kuo CH, Chuah SK. A real world report on intravenous high-dose and non-high-dose proton-pump inhibitors therapy in patients with endoscopically treated high-risk peptic ulcer bleeding. Gastroenterol Res Pract. 2012 July; 2012:858612. (SCI)

    • Tai WC, Hu TH, Lee CH, Chen HH, Huang CC, Chuah SK*. A no-perianal tuberculosis: 15 years of clinical experiences in Southern Taiwan. Colorectal Dis. 2010 Jul;12(7 Online):e114-20. (SCI)

    • Tai WC, Changchien CS, Hu TH, Huang CC, Chuah SK*, Lee CM. Pancreatic head cancer with distant duodenal metastasis: a case report with rare endoscopic presentations. Am J Med Sci. 2009 Jul;338(1):75-7. (SCI)

    • Tai WC, Hu TH, Wang JH, Hung CH, Lu SN, Changchien CS, Lee CM*. Clinical implications of alpha-fetoprotein in chronic hepatitis C. J Formos Med Assoc. 2009 Mar;108(3):210-8. (SCI)

    • Tai WC, Chuah SK, Lin JW, Chen HH, Huang HY, Kuo CM, Yi LN, Lee CM, Changchien CS, Hu TH*. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors. Oncol Rep. 2008 Nov;20(5):1157-64. (SCI)

    • Liang CM, Wu KL, Chou YP, Tai WC*, Chiu YC, Changchien CS, Chiou SS, Hu TH, Chuah SK. PREVALENCE AND ASSOCIATED FACTORS OF HYPERECHOIC PANCREAS ON SONOGRAPHY. Gastroenterol J Taiwan 2011; 28(3): 281-288.

    • Tai WC, Kuo CM, Lee CH, Chuah SK*, Huang CC, Hu TH, Wang JH, Chang KC, Tseng PL, Changchien CS, Lee CM. Liver Tuberculosis in Southern Taiwan: 15-years Clinical Experience. J Int Med Taiwan. 2008 Oct;19(5):410-7.